Dianthus Therapeutics, Inc. /DE/ financial data

Symbol
DNTH on Nasdaq
Location
New York, NY
Fiscal year end
31 December
Latest financial report
09 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1482% % -40%
Debt-to-equity 6.7% % 62%
Return On Equity -39% % -62%
Return On Assets -36% % -59%
Operating Margin -8739% % -435%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 44,471,094 shares 38%
Common Stock, Shares, Outstanding 43,223,090 shares 39%
Entity Public Float $599,400,000 USD -7.9%
Common Stock, Value, Issued $43,000 USD 39%
Weighted Average Number of Shares Outstanding, Basic 38,617,580 shares 16%
Weighted Average Number of Shares Outstanding, Diluted 38,617,580 shares 16%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $2,036,000 USD -67%
Revenue from Contract with Customer, Excluding Assessed Tax $2,036,000 USD -67%
Research and Development Expense $145,638,000 USD 75%
General and Administrative Expense $34,331,000 USD 37%
Operating Income (Loss) $177,933,000 USD -75%
Nonoperating Income (Expense) $15,596,000 USD -7.7%
Net Income (Loss) Attributable to Parent $162,337,000 USD -91%
Earnings Per Share, Basic -4.2 USD/shares -65%
Earnings Per Share, Diluted -4.2 USD/shares -65%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $51,087,000 USD 124%
Cash, Cash Equivalents, and Short-term Investments $50,247,000 USD 129%
Accounts Receivable, after Allowance for Credit Loss, Current $52,000 USD
Other Assets, Current $86,000 USD -76%
Assets, Current $409,438,000 USD 46%
Property, Plant and Equipment, Net $296,000 USD 53%
Operating Lease, Right-of-Use Asset $1,337,000 USD -14%
Assets $530,922,000 USD 42%
Accounts Payable, Current $9,725,000 USD 112%
Employee-related Liabilities, Current $9,517,000 USD 85%
Accrued Liabilities, Current $19,452,000 USD 49%
Liabilities, Current $30,732,000 USD 67%
Operating Lease, Liability, Noncurrent $1,019,000 USD -13%
Liabilities $37,521,000 USD 74%
Accumulated Other Comprehensive Income (Loss), Net of Tax $489,000 USD 361%
Retained Earnings (Accumulated Deficit) $336,729,000 USD -93%
Stockholders' Equity Attributable to Parent $493,401,000 USD 40%
Liabilities and Equity $530,922,000 USD 42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $27,630,000 USD -85%
Net Cash Provided by (Used in) Financing Activities $161,000 USD -100%
Net Cash Provided by (Used in) Investing Activities $14,794,000 USD
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 43,223,090 shares 39%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $12,675,000 USD -106%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $51,254,000 USD 123%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Deferred Tax Assets, Valuation Allowance $235,293,000 USD 30%
Deferred Tax Assets, Gross $235,773,000 USD 30%
Operating Lease, Liability $1,386,000 USD -7%
Depreciation $111,000 USD 16%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $161,954,000 USD -91%
Lessee, Operating Lease, Liability, to be Paid $1,707,000 USD -11%
Property, Plant and Equipment, Gross $600,000 USD 55%
Operating Lease, Liability, Current $367,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Two $323,000 USD 21%
Lessee, Operating Lease, Liability, to be Paid, Year One $367,000 USD 14%
Operating Lease, Weighted Average Discount Rate, Percent 0.084 pure -0.83%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $321,000 USD -26%
Lessee, Operating Lease, Liability, to be Paid, Year Three $318,000 USD 1.3%
Deferred Tax Assets, Operating Loss Carryforwards $132,723,000 USD 21%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $321,000 USD 0.94%
Operating Lease, Payments $300,000 USD -25%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $480,000 USD 111%
Share-based Payment Arrangement, Expense $22,793,000 USD 77%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%